Deborah T Blumenthal1, Lisa A Cannon-Albright. 1. Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Sackler Faculty of Medicine, Tel-Aviv 64239, Israel. dvorab@tasmc.health.gov.il
Abstract
BACKGROUND: Familiality in brain tumors is not definitively substantiated. METHODS: We used the Utah Population Data Base (UPDB), a genealogy representing the Utah pioneers and their descendants, record-linked to statewide cancer records, to describe the familial nature of primary brain cancer. We examined the familial clustering of primary brain tumors, including subgroups defined by histologic type and age at diagnosis. The UPDB includes 1,401 primary brain tumor cases defined as astrocytoma or glioblastoma, all with at least three generations of genealogy data. We tested the hypothesis of excess relatedness of brain tumor cases using the Genealogical Index of Familiality method. We estimated relative risks for brain tumors in relatives using rates of brain tumors estimated internally. RESULTS: Significant excess relatedness was observed for astrocytomas and glioblastomas considered as a group (n = 1,401), for astrocytomas considered separately (n = 744), but not for glioblastomas considered separately (n = 658). Significantly increased risks to first- and second-degree relatives for astrocytomas were identified for relatives of astrocytomas considered separately. Significantly increased risks to first-degree relatives, but not second degree, were observed for astrocytoma and glioblastoma cases considered together, and for glioblastoma cases considered separately. CONCLUSIONS: This study provides strong evidence for a familial contribution to primary brain cancer risk. There is evidence that this familial aspect includes not only shared environment, but also a heritable component. Extended high-risk brain tumor pedigrees identified in the UPDB may provide the opportunity to identify predisposition genes responsible for familial brain tumors.
BACKGROUND: Familiality in brain tumors is not definitively substantiated. METHODS: We used the Utah Population Data Base (UPDB), a genealogy representing the Utah pioneers and their descendants, record-linked to statewide cancer records, to describe the familial nature of primary brain cancer. We examined the familial clustering of primary brain tumors, including subgroups defined by histologic type and age at diagnosis. The UPDB includes 1,401 primary brain tumor cases defined as astrocytoma or glioblastoma, all with at least three generations of genealogy data. We tested the hypothesis of excess relatedness of brain tumor cases using the Genealogical Index of Familiality method. We estimated relative risks for brain tumors in relatives using rates of brain tumors estimated internally. RESULTS: Significant excess relatedness was observed for astrocytomas and glioblastomas considered as a group (n = 1,401), for astrocytomas considered separately (n = 744), but not for glioblastomas considered separately (n = 658). Significantly increased risks to first- and second-degree relatives for astrocytomas were identified for relatives of astrocytomas considered separately. Significantly increased risks to first-degree relatives, but not second degree, were observed for astrocytoma and glioblastoma cases considered together, and for glioblastoma cases considered separately. CONCLUSIONS: This study provides strong evidence for a familial contribution to primary brain cancer risk. There is evidence that this familial aspect includes not only shared environment, but also a heritable component. Extended high-risk brain tumor pedigrees identified in the UPDB may provide the opportunity to identify predisposition genes responsible for familial brain tumors.
Authors: F M Cicuttini; S F Hurley; A Forbes; G A Donnan; M Salzberg; G G Giles; J J McNeil Journal: Int J Cancer Date: 1997-04-10 Impact factor: 7.396
Authors: Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding Journal: Science Date: 1994-10-07 Impact factor: 47.728
Authors: S V Tavtigian; J Simard; J Rommens; F Couch; D Shattuck-Eidens; S Neuhausen; S Merajver; S Thorlacius; K Offit; D Stoppa-Lyonnet; C Belanger; R Bell; S Berry; R Bogden; Q Chen; T Davis; M Dumont; C Frye; T Hattier; S Jammulapati; T Janecki; P Jiang; R Kehrer; J F Leblanc; J T Mitchell; J McArthur-Morrison; K Nguyen; Y Peng; C Samson; M Schroeder; S C Snyder; L Steele; M Stringfellow; C Stroup; B Swedlund; J Swense; D Teng; A Thomas; T Tran; M Tranchant; J Weaver-Feldhaus; A K Wong; H Shizuya; J E Eyfjord; L Cannon-Albright; M Tranchant; F Labrie; M H Skolnick; B Weber; A Kamb; D E Goldgar Journal: Nat Genet Date: 1996-03 Impact factor: 38.330
Authors: A Kamb; D Shattuck-Eidens; R Eeles; Q Liu; N A Gruis; W Ding; C Hussey; T Tran; Y Miki; J Weaver-Feldhaus Journal: Nat Genet Date: 1994-09 Impact factor: 38.330
Authors: Ruby Del Risco Kollerud; Lisa A Cannon-Albright; Hege S Haugnes; Ellen Ruud; Magne Thoresen; Per Nafstad; Karl Gerhard Blaasaas; Øyvind Naess; Bjørgulf Claussen Journal: Pediatr Blood Cancer Date: 2020-05-21 Impact factor: 3.167
Authors: Philip Jonsson; Andrew L Lin; Robert J Young; Natalie M DiStefano; David M Hyman; Bob T Li; Michael F Berger; Ahmet Zehir; Marc Ladanyi; David B Solit; Angela G Arnold; Zsofia K Stadler; Diana Mandelker; Michael E Goldberg; Juliann Chmielecki; Maryam Pourmaleki; Shahiba Q Ogilvie; Shweta S Chavan; Andrew T McKeown; Malbora Manne; Allison Hyde; Kathryn Beal; T Jonathan Yang; Craig P Nolan; Elena Pentsova; Antonio Omuro; Igor T Gavrilovic; Thomas J Kaley; Eli L Diamond; Jacqueline B Stone; Christian Grommes; Adrienne Boire; Mariza Daras; Anna F Piotrowski; Alexandra M Miller; Philip H Gutin; Timothy A Chan; Viviane S Tabar; Cameron W Brennan; Marc Rosenblum; Lisa M DeAngelis; Ingo K Mellinghoff; Barry S Taylor Journal: Clin Cancer Res Date: 2019-07-01 Impact factor: 12.531
Authors: K Hemminki; S Tretli; J H Olsen; L Tryggvadottir; E Pukkala; J Sundquist; C Granström Journal: Br J Cancer Date: 2010-05-25 Impact factor: 7.640
Authors: Bradley S Peterson; Zhishun Wang; Guillermo Horga; Virginia Warner; Bret Rutherford; Kristin W Klahr; Barbara Graniello; Priya Wickramaratne; Felix Garcia; Shan Yu; Xuejun Hao; Phillip B Adams; Ming Qian; Jun Liu; Andrew Gerber; Myrna M Weissman Journal: JAMA Psychiatry Date: 2014-02 Impact factor: 21.596
Authors: Daniel I Jacobs; Kazutaka Fukumura; Matthew N Bainbridge; Georgina N Armstrong; Spiridon Tsavachidis; Xiangjun Gu; Harsha V Doddapaneni; Jianhong Hu; Joy C Jayaseelan; Donna M Muzny; Jason T Huse; Melissa L Bondy Journal: Neuro Oncol Date: 2018-11-12 Impact factor: 12.300
Authors: Lisa A Cannon-Albright; James M Farnham; Jeffrey Stevens; Craig C Teerlink; Cheryl A Palmer; Kerry Rowe; Melissa H Cessna; Deborah T Blumenthal Journal: Neuro Oncol Date: 2021-02-25 Impact factor: 12.300